MD: Hematology – Oncology
Ran Reshef, MD, is an Associate Professor of Medicine at Columbia University Medical Center and the Director of Translational Research for the Hematologic Malignancies and Stem-cell Transplant Program at Columbia University. He is also a Principal Investigator at the Herbert Irving Comprehensive Cancer Center at Columbia University. Prior to his current position, Dr. Reshef spent 8 years at the University of Pennsylvania, where he treated patients with hematologic malignancies and conducted translational research in cancer immunotherapy, stem-cell transplantation and cellular therapy. Dr. Reshef specializes in malignant hematological disorders such as leukemia, lymphoma, MDS and multiple myeloma. His research experience and interests focus on cancer immunotherapy, drug development in leukemia, lymphoma and myeloma and the study of novel cellular therapies. He is the principal investigator of clinical trials involving drug therapy for hematologic cancers. He has published his original research in high impact journals such as the New England Journal of Medicine, Journal of Clinical Oncology, Blood, American Journal of transplantation and others. He is also associate with the clinical trials Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease and Phase II Maraviroc for GVHD Prevention. He is also a member of the steering committee of the Bone Marrow Transplant Clinical Trials Network.